The Galien Foundation announces the winners of the Galien International Prize and Prix Galien Italia 2024

Recipients set the standard for scientific advances that improve human health

NEW YORK, June 21, 2024 /PRNewswire/ — The Galien Foundation, the leading global institution dedicated to honoring innovators in the life sciences, today announced the winners of the 2024 International Prix Galien Awards and Prix Galien Italy Awards, hosted in June 20 at Hotel Parco dei Principi Grand, in Rome.

“We are honored to host Prix Galien Italia and International Prix Galien together, bringing together the most forward-thinking innovators across the life sciences here at Italand around the world”, said Pr. Pier Luigi Canonico, Chairman of the Prix Galien Italy and International Prix Galien Awards Committee. “It is exciting to welcome those who have excelled in pursuing scientific progress to the global stage, and we look forward to seeing their continued success as Prix Galien alumni.”

Awards for “Advanced Therapy Medicinal Products”, “Best Biological Drug”, “Best Chemical Synthesis Drug”, “Best Chemical-Biotechnological Drug”, “Best Orphan Drug”, “Most Evidence real-world best” and “Best vaccine” were awarded. presented to industry leaders committed to innovation that improves the human condition. In addition to awarding this year's Prix Galien Italy winners, the winners of the International Prix Galien Prize were selected from laureates who were previously awarded a national Prix Galien in 2022 and 2023. The winners were selected in the following categories: “Best Product Best Biotech”, “Best Digital Health Solution”, “Best Medical Technology”, “Best Pharmaceutical Product” and “Best Vaccine”.

“The Galien Foundation is dedicated to raising talent in the life sciences industries and rewarding landmark achievements in a wide range of complex and challenging medical fields. With the start of the summer season, Prix Galien Italy and International Prix Galien offer us an opportunity to celebrated a summer of therapeutic innovation”, said Bruno Cohen, Chairman of the Galien Foundation. “We express our utmost gratitude to our International Prix Galien and Prix Galien Italy 2024 winners, who have proven that persistence, dedication and continuous innovation for the future of healthcare is paving the way for us all.”

The International Prix Galien Awards is organized once every two years, inviting candidates who have previously won a National Prix Galien award in the two years prior to the International Awards ceremony. The next host International Prix Galien will be held in March 2026IN New Delhi.

Winners of the International Prix Galien 2024

Prix ​​Galien International Awards Committee

Ital PR PIER LUIGI CANONICO
Committee Chair, Emeritus Professor of Pharmacology, University of Eastern Piedmont Amedeo Avogadro

Africa PR AWA MARIE COLL SECK
Chair, Galen Africa; Former senior minister of the President of the Republic of SENEGALformer Minister of Health

Belgium Luxembourg PR JAN DE HOON
Professor in Pharmacology / Clinical Pharmacology, UPC KULeuven

Canada PR ERNESTO L. SCHIFFRIN
Chief Physician, Department of Medicine, Jewish General Hospital; Director, Hypertension and Vascular Research Unit, Lady Davis Institute for Medical Research; Dear James McGill Professor and Associate Chair, Department of Medicine, McGill University

France Dr. ANNICK FOR YOU
Head of the Clinical Trials Department, AGEPS, AP-HP; Leading Associate Professor of UP “Pharmaceutical Development and Innovation”, Faculty of Pharmacy, University of Paris

Germany ERLAND ERDMANN
Professor Emeritus, University of Cologne | UOC – Division of Cardiology, Pneumology, Angiology and Intensive Care, Kln

Greece PR GEORGES P. CHROUSOS
Professor, School of Medicine, National and Kapodistrian School of Athens

INDIA MANJU SHARMA PR
Former Secretary of the Government of INDIA, Department of Biotechnology; Chairman, New Initiative, NASI, Allahabad

Netherlands
PR DR KOOS BURGGRAAF
CEO, Center for Human Drug Research; Professor, Division of Pharmacology Leiden Academic Center for Drug Research, University of Leiden

PR DR LISETE VAN GEMERT-PINEN
Full Professor Persuasive Health Technology, University of Twenteand Visiting Professor, University of Waterloo

Poland PR Cezary Szczylik
Polish Professor of Medical Sciences specializing in Oncology, Hematology and Internal Medicine

Switzerland PR CHRISTOPH RENNER
Professor of Hematology – General Internal Medicine – Medical Oncology

United Kingdom PR GOD MUNIR PIRMOHAMED
Chair of Medicine David Weatherall, University of Liverpool; NHS Chair of Pharmacogenetics

United States PR MICHAEL ROSENBLATT
The former dean of Tufts University School of MedicineFormer Chief Medical Officer of Merck & Co. Inc.

Winners of the Prix Galien Italy 2024

Prix ​​Galien Italy 2024 Special Mentions

Prix ​​Galien Italy Awards Committee

PR PIER LUIGI CANONICO
Committee Chair, Emeritus Professor of Pharmacology, University of Eastern Piedmont Amedeo Avogadro

PR ALBERTO CORSINI
University of Milan

PR ANNAMARIA DE LUCA
University of Shepherd Aldo Moro

PR MAURIZIO D'INCALCI
Humanitas University in Milan

PR TULLIO FLORIO
University of Genoa

PR MARIAGRAZIA GRILLI
University of Eastern Piedmont

PR CARLO RICARDI
University of Perugia

PR MARIA ANGELA SORTINO
University of Catania

PR MAURIZIO CHANGED IT
Vanvitelli University i Naples

PR LUIGIA TRABACE
University of Foggia

PR STEFANO VELLA
Catholic University of the Sacred Heart, ROMA

About the Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatments and technologies that will impact the state of medical practice and save lives. Late professor Elie WieselNobel Peace Laureate 1986, is the Founding Honorary President of the Galien Foundation

The foundation oversees and directs US activities for the Prix Galien, an international awards program dedicated to progress through the development of innovative medicines, with chapters in 14 countries, Africa and an inaugural chapter established in INDIA in 2024. Prix Galien was established in 1970 by Roland Mehl in honor of Galen, the father of modern medical science and pharmacology. Worldwide, the Prix Galien is considered the equivalent of the Nobel Prize in biopharmaceutical research.

For more information, visit www.galienfoundation.org.

Follow the Foundation on social networks:
https://www.facebook.com/GalienFoundation/
https://twitter.com/GalienFdn
https://www.linkedin.com/company/the-galien-foundation/

Media contact:
Kara Bradley
Finnish partners
[email protected]
+1 646-213-7243

SOURCE Galien Foundation